Geode Capital Management, LLC Citius Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,878,953 shares of CTXR stock, worth $5.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,878,953
Previous 1,646,297
14.13%
Holding current value
$5.47 Million
Previous $954,000
1.57%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CTXR
# of Institutions
61Shares Held
23.7MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$21.2 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$5.25 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$3.37 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ932KShares$2.71 Million0.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $425M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...